Sign inJoin waitlistJoin the waitlist

MZ

Mark Zangardi

Pharmacist / Oncology

Credentials: · ·

History

Tufts Medical Center
2014–2015

Research

CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions
Review · Current Oncology Reports · 2019 · 132 citations
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
Review · The Oncologist · 2017 · 130 citations
Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience
Journal of the National Comprehensive Cancer Network · 2021 · 81 citations

Aditya Bardia
6 papers
LS
Laura Spring
6 papers · 2 as a fellow
Beverly Moy
3 papers
Eejung Kim
2 papers
LE
Leif Ellisen
2 papers
SW
Seth Wander
2 papers · 1 as a fellow
SI
Steven Isakoff
2 papers
Therese Mulvey
2 papers
AB
Adam Brufsky
1 paper
AP
Apurva Pandey
1 paper
Areej El-Jawahri
1 paper
Azadeh Nasrazadani
1 paper · 1 as a fellow